Belatacept: a novel immunosuppressive agent for kidney transplant recipients
about
Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathyMultipotent mesenchymal stromal cells synergize with costimulation blockade in the inhibition of immune responses and the induction of Foxp3+ regulatory T cells.Infectious complications of immune modulatory agents.Belatacept for renal rescue in lung transplant patients.Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.
P2860
Belatacept: a novel immunosuppressive agent for kidney transplant recipients
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2012
@uk
name
Belatacept: a novel immunosuppressive agent for kidney transplant recipients
@en
Belatacept: a novel immunosuppressive agent for kidney transplant recipients
@nl
type
label
Belatacept: a novel immunosuppressive agent for kidney transplant recipients
@en
Belatacept: a novel immunosuppressive agent for kidney transplant recipients
@nl
prefLabel
Belatacept: a novel immunosuppressive agent for kidney transplant recipients
@en
Belatacept: a novel immunosuppressive agent for kidney transplant recipients
@nl
P2860
P356
P1476
Belatacept: a novel immunosuppressive agent for kidney transplant recipients
@en
P2093
Bernard Charpentier
P2860
P304
P356
10.1586/ECI.12.79
P407
P577
2012-11-01T00:00:00Z